Request Demo!

Press Releases

ZMD sells interest in its ZRx Prescriber for up to $6,800,000.

ZoomMed to focus on U.S. market by selling to TELUS Health an interest in its ZRx Prescriber Technology and related Canadian operations   Montreal, September 3, 2014 – ZoomMed Inc. (TSX-V: ZMD) – ZoomMed has sold an interest in the technology underlying its ZRx Prescriber Technology and certain related Canadian operations to TELUS Health for up…

Read More

ZoomMed signs an agreement with Desjardins Insurance DSF

Montreal, February 17, 2014 – ZoomMed Inc. (TSX-V: ZMD) (the “Company” or “ZoomMed”) is pleased to announce that it has signed an agreement with Desjardins Insurance for the development and operation of a project focusing for a web-based solution to integrate selected insurance plan information into the ZRx Prescriber to provide physician users with information…

Read More

Closing of a new financing and the repayment of its $1,5M convertible debenture

Montreal, January 16, 2014 – ZoomMed Inc. (TSX-V: ZMD) (the “Corporation”) announces the closing of a non-revolving loan, for a principal amount not exceeding US$2,000,000 (the “Loan”), of which US$1,664,318.92 has already been advanced, and the repayment of the CA$1,500,000 current convertible debenture.     The new secured debenture’s maturity date is December 31, 2014…

Read More